• Proactive - Interviews for investors

  • By: Proactive
  • Podcast
Proactive - Interviews for investors By cover art

Proactive - Interviews for investors

By: Proactive
Listen for free

  • Summary

  • Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage. Here we plug you into what’s new and exciting in the world of business.
    Show more Show less
Episodes
  • Nevis Brands Expands Major Distribution with Exclusive Licensing Agreement in Mississippi

    Nevis Brands Expands Major Distribution with Exclusive Licensing Agreement in Mississippi
    Apr 30 2024
    Nevis Brands CEO John Kueber joined Steve Darling from Proactive to announce the company has announced a significant expansion in Major's distribution through an exclusive licensing agreement with Stash House for production and distribution in Mississippi. Under this agreement, Stash House will have exclusive rights to produce and distribute the full lineup of Major products in the state. The Major lineup includes dose-able 100mg THC beverages available in flavors such as Blueberry, Fruit Punch, and Blackberry Lemonade. Known for delivering the effects of cannabis within a short timeframe of 10-20 minutes after consumption, Major has gained popularity since its initial launch in Washington State in 2019, with over 5 million bottles sold to date. Kueber highlighted Mississippi's recent legalization of cannabis for medical use in January 2023, which has led to the licensing of over 400 dispensaries in the state. This agreement marks Major's entry into its 10th state for production, further expanding its reach across the United States. Currently available in Washington, Oregon, Arizona, Ohio, Colorado, Nevada, California, and Missouri, Major is also preparing for production in Michigan, signaling the brand's continued growth and market penetration. #proactiveinvestors #nevisbrandsinc #cannabis #sorse #major #thc #JohnKueber, #cannabisbeverages, #MississippiMarket, #StashHouse, #cannabisindustry, #cannabistourism, #edibles, #MajorBeverage, #beverageindustry, #cannabislegalization, #recreationalcannabis, #cannabissales, #UScannabismarket, #cannabisexpansion, #beveragelaunch, #marketentry, #cannabisregulation, #cannabiseducation, #beverageflavours#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Show more Show less
    4 mins
  • BioHarvest Sciences Reports Strong Financial Performance for 2023, Eyes Nasdaq Listing

    BioHarvest Sciences Reports Strong Financial Performance for 2023, Eyes Nasdaq Listing
    Apr 30 2024
    BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to share the company's impressive financial and operational results for the fourth quarter and full year ended December 31, 2023. Revenue surged by 131% to $12.7 million in 2023, compared to $5.5 million in 2022, with fourth quarter revenue growing by 85% to $4.5 million. Notably, gross margins for the fourth quarter improved to 51%, up from 27% in the same period of 2022, and full-year gross margins rose to 45%, from 22% in 2022. In the US market, BioHarvest Sciences experienced significant growth, with new customer and subscriber counts more than doubling. Despite this growth, marketing costs increased by only 48%, while customer churn and cost of acquisition decreased, indicating improved efficiency in customer acquisition and retention strategies. Looking ahead, Sobel provided revenue guidance for the first and second quarters of 2024, expecting revenues to range between $5.2-$5.3 million and $5.7-$6.0 million, respectively. The company also launched a new 'Hot Beverage' lineup in December 2023, starting with VINIA® Functional Coffees, with additional VINIA® products in the pipeline. In a strategic move towards broader market access, BioHarvest Sciences is working towards listing on the Nasdaq Exchange in the United States. To meet Nasdaq's minimum share price requirements, the company plans to seek shareholder approval for a share consolidation of 35-1 at its Annual and Special General Meeting on May 27, 2024. Additionally, the company aims to enhance corporate governance by adding an additional independent director to meet Nasdaq requirements. These initiatives underscore BioHarvest Sciences' commitment to unlocking greater shareholder value and expanding its presence in the US market. #proactivinvestors #cse #bhsc #otcqb #cnvcf #pharma #biotech #hearthealth #BioHarvestSciences, #IlanSobel, #RevenueGrowth, #NasdaqListing, #FinancialResults, #MarketingEfficiency, #ProductLaunch, #CoffeeProducts, #TeaProducts, #BusinessGrowth, #InvestorInterest, #BusinessStrategy, #FinancialForecast, #MarketExpansion, #CorporateDevelopment, #ManagementFocus, #EarningsReport, #StockMarket, #InvestmentOpportunity, #CorporateNews #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Show more Show less
    7 mins
  • Cloud DX Reports Significant Revenue and Profit Growth in 2023

    Cloud DX Reports Significant Revenue and Profit Growth in 2023
    Apr 30 2024
    Cloud DX CEO Robert Kaul joined Steve Darling from Proactive to discuss the company's impressive performance in its 2023 full-year results. Notably, Cloud DX reported a substantial 55.4% increase in revenue, reaching $1.8 million. A key driver of this growth was the remarkable surge in subscription revenue, which soared by nearly 70%, surpassing the overall revenue increase. This shift towards subscription revenue, characterized by high margins exceeding 90%, has significantly bolstered profitability, with gross profit doubling to $1.2 million, reflecting a remarkable 112% increase. The company's stellar performance is further underscored by its operational efficiency, as evidenced by a noteworthy $1.3 million reduction in operating expenses. This reduction was achieved through strategic staff cost management, executed without compromising on customer service quality. As a result, Cloud DX achieved a more than 20% decrease in operating loss, setting a positive trajectory towards profitability and positive cash flow in the coming quarters. Looking ahead, Cloud DX is well positioned to solidify its presence in the remote patient monitoring market in Canada. The company boasts the largest share of provincial contracts and maintains robust partnerships with major industry players such as Medtronic and Teladoc Health. Moreover, Cloud DX's successful early conversion of convertible debt at a premium underscores its strong financial management and commitment to enhancing shareholder value. #proactiveinvestors #clouddxinc #tsxv #cdx #otc #cdxff #medical #remotemonitoring #RemotePatientMonitoring #HealthTech #RevenueGrowth #SubscriptionModel #SaaS #Profitability #OperationalEfficiency #TechInnovation #HealthcareIndustry #CanadianTech #Medtronic #TeladocHealth #HealthPartnerships #FinancialPerformance #TechInvestment #CloudTechnology #DigitalHealth #HealthcareSolutions #PatientCare#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
    Show more Show less
    5 mins
Business & Careers Economics Personal Finance Politics & Government
Show more Show less

What listeners say about Proactive - Interviews for investors

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available